Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cavosonstat for COPD Exacerbations
NCT04600778Phase 2Unknown
- Sponsor
- GSNOR Therapeutics
- Start
- Feb 2021
- Primary completion
- Dec 2021
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of cavosonstat in chronic obstructive pulmonary disease (COPD), sponsored by GSNOR Therapeutics. Status: unknown.
02
Drugs
cavosonstat
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT04600778.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04600778.